Neuropathological studies have found MEF2C to be associated with Braak stage, capillary Aβ and neuritic plaques suggesting a contributory role of this gene to Alzheimer’s disease and Lewy body disease (Beecham et al., 2014; Mäkelä et al., 2018). This evidence concerns the gene MEF2C and Alzheimer disease.